Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 6: 36659, 2016 11 11.
Article in English | MEDLINE | ID: mdl-27834402

ABSTRACT

Macrophages, key cells of the innate immune system, are known to support angiogenesis but are not believed to directly form vessel walls. Here we show that macrophages structurally form primitive, NON-ENDOTHELIAL "vessels" or vascular mimicry (VM) channels in both tumor and angiogenesis in vivo models. These channels are functionally connected to the systemic vasculature as they are perfused by intravenously injected dye. Since both models share hypoxic micro-environments, we hypothesized that hypoxia may be an important mediator of VM formation. Indeed, conditional genetic depletion of myeloid-specific HIF-1α results in decreased VM network formation, dye perfusion and tumor size. Although the macrophage VM network shares some features with an endothelial vasculature, it is ultrastructurally different. Cancer stem cells have been shown to form vascular mimicry channels. Our data demonstrates that tumor-associated macrophages also form them. The identification of this novel type of vascular mimicry may help in the development of targeted cancer therapeutics.


Subject(s)
Blood Vessels/immunology , Macrophages/immunology , Neoplastic Stem Cells/immunology , Animals , Blood Vessels/pathology , Cell Hypoxia/immunology , Macrophages/pathology , Mice , Mice, Nude , Mice, Transgenic , Neoplastic Stem Cells/pathology
2.
Proc Natl Acad Sci U S A ; 104(3): 967-72, 2007 Jan 16.
Article in English | MEDLINE | ID: mdl-17210921

ABSTRACT

Angiostatic therapies designed to inhibit neovascularization associated with multiple pathological conditions have only been partially successful; complete inhibition has not been achieved. We demonstrate synergistic effects of combining angiostatic molecules that target distinct aspects of the angiogenic process, resulting in the complete inhibition of neovascular growth associated with development, ischemic retinopathy, and tumor growth, with little or no effect on normal, mature tissue vasculature. Tumor vascular obliteration using combination angiostatic therapy was associated with reduced tumor mass and increased survival in a rat 9L gliosarcoma model, whereas individual monotherapies were ineffective. Significant compensatory up-regulation of several proangiogenic factors was observed after treatment with a single angiostatic agent. In contrast, treatment with combination angiostatic therapy significantly reduced compensatory up-regulation. Therapies that combine angiostatic molecules targeting multiple, distinct aspects of the angiogenic process may represent a previously uncharacterized paradigm for the treatment of many devastating diseases with associated pathological neovascularization.


Subject(s)
Angiogenesis Inhibitors/therapeutic use , Eye/blood supply , Eye/drug effects , Neoplasms/blood supply , Neoplasms/drug therapy , Animals , Animals, Newborn , Drug Therapy, Combination , Male , Neoplasms/pathology , Neovascularization, Pathologic , Rats , Survival Rate , Up-Regulation
SELECTION OF CITATIONS
SEARCH DETAIL
...